Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells

Heart failure is a consequence of progression hypoxia‐dependent tissue damages. Therapeutic approaches to restore and/or protect the healthy cardiac tissue have largely failed and remain a major challenge of regenerative medicine. The myo‐inositol trispyrophosphate (ITPP) is a modifier of haemoglobi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cell Mol Med
Hlavní autoři: Oknińska, Marta, El‐Hafny‐Rahbi, Bouchra, Paterek, Aleksandra, Mackiewicz, Urszula, Crola‐Da Silva, Claire, Brodaczewska, Klaudia, Mączewski, Michał, Kieda, Claudine
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011163/
https://ncbi.nlm.nih.gov/pubmed/31957267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14909
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky